Jeffrey Cohn

2.0k total citations · 1 hit paper
19 papers, 1.5k citations indexed

About

Jeffrey Cohn is a scholar working on Cognitive Neuroscience, Cellular and Molecular Neuroscience and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Jeffrey Cohn has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cognitive Neuroscience, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Jeffrey Cohn's work include Neuroscience and Neuropharmacology Research (4 papers), Memory and Neural Mechanisms (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). Jeffrey Cohn is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Memory and Neural Mechanisms (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). Jeffrey Cohn collaborates with scholars based in United States, Netherlands and Italy. Jeffrey Cohn's co-authors include Thomas M. Habermann, Edie Weller, B. A. Peterson, Peter A. Cassileth, Bruce A. Woda, Sandra J. Horning, Randy D. Gascoyne, Richard I. Fisher, Vicki A. Morrison and Shaker R. Dakhil and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Jeffrey Cohn

19 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

2006 997 citations Thomas M. Habermann, Edie Weller et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Jeffrey Cohn

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Cohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Cohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Cohn more than expected).

Fields of papers citing papers by Jeffrey Cohn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Cohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Cohn. The network helps show where Jeffrey Cohn may publish in the future.

Co-authorship network of co-authors of Jeffrey Cohn

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Cohn. A scholar is included among the top collaborators of Jeffrey Cohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Cohn. Jeffrey Cohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Maintenance rituximab (MR) compared to observation (OBS) after R-CHOP or CHOP in older patients (pts) with diffuse large B-cell lymphoma (DLBCL): An Intergroup E4494/C9793 update 2007 ·Journal of Clinical Oncology ·V. A. Morrison, Edie Weller, Thomas M. Habermann, Peter A. Cassileth, Jeffrey Cohn, Randy D. Gascoyne, Bruce A. Woda, Richard I. Fisher, B. A. Peterson, Sandra J. Horning	14
2	Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy. 2006 ·PubMed ·Howard A. Burris, Paul J. Hesketh, Jeffrey Cohn, (unknown), Timothy Ryan, C. Friedman, David Fitts	2
3	Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma breakdown → 2006 ·Journal of Clinical Oncology ·Thomas M. Habermann, Edie Weller, Vicki A. Morrison, Randy D. Gascoyne, Peter A. Cassileth, Jeffrey Cohn, Shaker R. Dakhil, Bruce A. Woda, Richard I. Fisher, B. A. Peterson, Sandra J. Horning	997
4	Rituximab-CHOP Versus CHOP with or without Maintenance Rituximab in Patients 60 Years of Age or Older with Diffuse Large B-Cell Lymphoma (DLBCL): An Update. 2004 ·Blood ·Thomas M. Habermann, Edie Weller, V. A. Morrison, Peter A. Cassileth, Jeffrey Cohn, (unknown), R. D. Gascoyne, Bruce A. Woda, R I Fisher, B. A. Peterson, SJ Horning	42
5	Interleaved Transcranial Magnetic Stimulation/Functional MRI Confirms that Lamotrigine Inhibits Cortical Excitability in Healthy Young Men 2004 ·Neuropsychopharmacology ·Xingbao Li, Charlotte C. Tenebäck, Ziad Nahas, F. Andrew Kozel, Charles H. Large, Jeffrey Cohn, Daryl E. Bohning, Mark S. George	67
6	Cytoprotection in Acute Myelogenous Leukemia (AML) therapy 2004 ·Seminars in Oncology ·(unknown), Joanne Filicko, Guillermo Garcia‐Manero, (unknown), Janet Brunner, Jeffrey Cohn, Andres Ferbér, José Antonio Martínez, Bijoyesh Mookerjee, (unknown), (unknown), John L. Wagner, Robert L. Capizzi, Neal Flomenberg	4
7	Acquisition, steady-state performance, and the effects of trimethyltin on the operant behavior and hippocampal GFAP of Long–Evans and Fischer 344 rats 2003 ·Neurotoxicology and Teratology ·Robert C. MacPhail, James P. O’Callaghan, Jeffrey Cohn	1
8	Phase II study of patients with metastatic nonsmall cell carcinoma of the lung treated with paclitaxel by 3-hour infusion 1997 ·Cancer ·William Tester, (unknown), (unknown), Jeffrey Cohn, Martin H. Cohen	39
9	Chlorpyrifos Produces Selective Learning Deficits in Rats Working Under a Schedule of Repeated Acquisition and Performance 1997 ·Journal of Pharmacology and Experimental Therapeutics ·Jeffrey Cohn, Robert C. MacPhail	26
10	Animal behavioral methods in neurotoxicity assessment: SGOMSEC joint report. 1996 ·Environmental Health Perspectives ·B.M. Kulig, Enrico Alleva, Giorgio Bignami, Jeffrey Cohn, Deborah A. Cory‐Slechta, (unknown), John L. O’Donoghue, David B. Peakall	30
11	Repeated acquisition and the assessment of centrally acting compounds 1996 ·Cognitive Brain Research ·Jeffrey Cohn, Robert C. MacPhail, Merle G. Paule	12
12	Acute trimethyltin exposure produces nonspecific effects on learning in rats working under a multiple repeated acquisition and performance schedule 1996 ·Neurotoxicology and Teratology ·Jeffrey Cohn, Robert C. MacPhail	5
13	Lead exposure potentiates the effects of NMDA on repeated learning 1994 ·Neurotoxicology and Teratology ·Jeffrey Cohn	31
14	Assessment of the role of dopaminergic systems in lead-induced learning impairments using a repeated acquisition and performance baseline. 1994 ·PubMed ·Jeffrey Cohn, Deborah A. Cory‐Slechta	11
15	The effects of lead exposure on learning in a multiple repeated acquisition and performance schedule. 1994 ·PubMed ·Jeffrey Cohn, (unknown), Deborah A. Cory‐Slechta	81
16	Subsensitivity of lead-exposed rats to the accuracy-impairing and rate-altering effects of MK-801 on a multiple schedule of repeated learning and performance 1993 ·Brain Research ·Jeffrey Cohn, Deborah A. Cory‐Slechta	45
17	Comparison of error patterns produced by scopolamine and MK-801 on repeated acquisition and transition baselines 1992 ·Psychopharmacology ·Jeffrey Cohn, John M. Ziriax, Christopher Cox, Deborah A. Cory‐Slechta	30
18	Lead retards development of Drosophila melanogaster 1992 ·Comparative Biochemistry and Physiology Part C Comparative Pharmacology ·Jeffrey Cohn, Dan Widzowski, Deborah A. Cory‐Slechta	19
19	Differential effects of MK-801, NMDA and scopolamine on rats learning a four-member repeated acquisition paradigm 1992 ·Behavioural Pharmacology ·Jeffrey Cohn, Deborah A. Cory‐Slechta	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact